5 Oct 2026, 10:03
Company Update—
ATHALTERITY THERAPEUTICS LIMITED
Announcement history available from 1 August 2025
Fromto
25 Sept 2026, 13:46
Meetings & Governance—
23 Sept 2026, 09:26
Presentations—
18 Sept 2026, 09:36
Company Administration—
16 Sept 2026, 12:36
Securities Administration—
8 Sept 2026, 11:59
Securities Administration—
8 Sept 2026, 11:41
Securities Administration—
3 Sept 2026, 09:26
Company Administration—
2 Sept 2026, 12:03
Director Interests—
2 Sept 2026, 12:02
Director Interests—
1 Sept 2026, 14:54
Securities Administration—
31 Aug 2026, 12:50
Company Administration—
31 Aug 2026, 09:51
Securities AdministrationMS
28 Aug 2026, 18:54
Securities Administration—
28 Aug 2026, 15:34
Company Administration—
28 Aug 2026, 15:33
Company Administration—
28 Aug 2026, 15:33
Financial ResultsMS
21 Aug 2026, 14:24
Securities Administration—
17 Aug 2026, 14:52
Company Administration—
14 Aug 2026, 16:08
Securities Administration—
12 Aug 2026, 08:36
Company UpdateMS
10 Aug 2026, 18:01
Securities Administration—
6 Aug 2026, 10:05
Company Administration—
3 Aug 2026, 16:22
Securities Administration—
30 July 2026, 10:00
Quarterly ReportsMS
29 July 2026, 09:01
Letters & Addresses—
28 July 2026, 10:57
Securities Administration—
21 July 2026, 17:02
Company Administration—
21 July 2026, 13:00
Securities Administration—
9 July 2026, 15:52
Periodic ReportsMS
9 July 2026, 11:40
Securities Administration—
7 July 2026, 09:44
Company UpdateMS
1 July 2026, 16:51
Securities Administration—
30 June 2026, 08:16
Substantial Holders—
17 June 2026, 11:54
Director Interests—
16 June 2026, 10:40
Presentations—
15 June 2026, 14:41
Securities Administration—
15 June 2026, 14:32
Securities Administration—
12 June 2026, 14:52
Securities Administration—
9 June 2026, 09:01
Company UpdateMS
4 June 2026, 09:49
Company Administration—
3 June 2026, 16:59
Securities Administration—
29 May 2026, 13:59
Meetings & Governance—
19 May 2026, 10:02
Company Update—
12 May 2026, 12:22
Presentations—
11 May 2026, 09:25
Company Update—
7 May 2026, 11:35
Company Administration—
30 Apr 2026, 11:45
Securities Administration—
30 Apr 2026, 09:53
Quarterly ReportsMS
29 Apr 2026, 12:54
PresentationsMS
| Date / Time | Heading | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 5 Oct 2026, 10:03 | Alterity Presents New Analyses of ATH434 Phase 2 Data in MSA | Company Update | — | 11001 | |
| 25 Sept 2026, 13:46 | Date of AGM and Closing Date for Director Nominations | Meetings & Governance | — | 08006 | |
| 23 Sept 2026, 09:26 | Corporate Presentation September 2026 | Presentations | — | 03026 | |
| 18 Sept 2026, 09:36 | Alterity Therapeutics to Present at ASX SMIDcaps Conference | Company Administration | — | 12008 | |
| 16 Sept 2026, 12:36 | Application for quotation of securities - ATH | Securities Administration | — | 06020 | |
| 8 Sept 2026, 11:59 | Cleansing Notice Under Section 708A | Securities Administration | — | 06018 | |
| 8 Sept 2026, 11:41 | Application for quotation of securities - ATH | Securities Administration | — | 06020 | |
| 3 Sept 2026, 09:26 | Alterity to Present at Cantor Global Healthcare Conference | Company Administration | — | 12008 | |
| 2 Sept 2026, 12:03 | Change of Director's Interest Notice - Stamler | Director Interests | — | 02009 | |
| 2 Sept 2026, 12:02 | Change of Director's Interest Notice - Marks | Director Interests | — | 02009 | |
| 1 Sept 2026, 14:54 | Application for quotation of securities - ATH | Securities Administration | — | 06020 | |
| 31 Aug 2026, 12:50 | Alterity Therapeutics Filed Form 20-F and XBRL Data with SEC | Company Administration | — | 12008 | |
| 31 Aug 2026, 09:51 | $4.2M Options Underwriting Agreement Executed | Securities Administration | MS | 06009 | |
| 28 Aug 2026, 18:54 | Application for quotation of securities - ATH | Securities Administration | — | 06020 | |
| 28 Aug 2026, 15:34 | Corporate Governance Statement | Company Administration | — | 03024 | |
| 28 Aug 2026, 15:33 | Appendix 4G | Company Administration | — | 03025 | |
| 28 Aug 2026, 15:33 | Appendix 4E and 2026 Annual Report | Financial Results | MS | 03001, 03002, 03003, 03011, 03012, 03013, 03020 | |
| 21 Aug 2026, 14:24 | Application for quotation of securities - ATH | Securities Administration | — | 06020 | |
| 17 Aug 2026, 14:52 | Disclosure Under Takeovers Panel GN 20 | Company Administration | — | 06009, 12008 | |
| 14 Aug 2026, 16:08 | Application for quotation of securities - ATH | Securities Administration | — | 06020 | |
| 12 Aug 2026, 08:36 | Granted New U.S. Composition of Matter Patent for ATH434 | Company Update | MS | 11001 | |
| 10 Aug 2026, 18:01 | Application for quotation of securities - ATH | Securities Administration | — | 06020 | |
| 6 Aug 2026, 10:05 | Alterity to Present at Canaccord Genuity Growth Conference | Company Administration | — | 12008 | |
| 3 Aug 2026, 16:22 | Application for quotation of securities - ATH | Securities Administration | — | 06020 | |
| 30 July 2026, 10:00 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19004, 19009 | |
| 29 July 2026, 09:01 | Upcoming Expiry of ATHO Listed Options | Letters & Addresses | — | 06009, 16001 | |
| 28 July 2026, 10:57 | Application for quotation of securities - ATH | Securities Administration | — | 06020 | |
| 21 July 2026, 17:02 | Alterity to Participate in the BTIG Biotechnology Conference | Company Administration | — | 12008 | |
| 21 July 2026, 13:00 | Application for quotation of securities - ATH | Securities Administration | — | 06020 | |
| 9 July 2026, 15:52 | ATH Receives A$3.98m R&D Tax Incentive | Periodic Reports | MS | 03014 | |
| 9 July 2026, 11:40 | Application for quotation of securities - ATH | Securities Administration | — | 06020 | |
| 7 July 2026, 09:44 | FDA Meeting Minutes Confirm Registrational Path for ATH434 | Company Update | MS | 11001 | |
| 1 July 2026, 16:51 | Application for quotation of securities - ATH | Securities Administration | — | 06020 | |
| 30 June 2026, 08:16 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 17 June 2026, 11:54 | Change of Director's Interest Notice x 2 | Director Interests | — | 02009 | |
| 16 June 2026, 10:40 | Corporate Presentation June 2026 | Presentations | — | 03026 | |
| 15 June 2026, 14:41 | Notification regarding unquoted securities - ATH | Securities Administration | — | 06021 | |
| 15 June 2026, 14:32 | Notification of cessation of securities - ATH | Securities Administration | — | 06027 | |
| 12 June 2026, 14:52 | Completion of Consolidation | Securities Administration | — | 06005, 06009 | |
| 9 June 2026, 09:01 | Alterity and FDA Agree on Phase 3 Program for ATH434 in MSA | Company Update | MS | 11001 | |
| 4 June 2026, 09:49 | Share Consolidation Effective, Trading Under ATHDA | Company Administration | — | 06005, 12008 | |
| 3 June 2026, 16:59 | Change of Registered Office Address | Securities Administration | — | 12003 | |
| 29 May 2026, 13:59 | Results of Meeting | Meetings & Governance | — | 08003 | |
| 19 May 2026, 10:02 | Alterity Data Supports ATH434 Phase 3 Advancement in MSA | Company Update | — | 11001 | |
| 12 May 2026, 12:22 | Corporate Presentation May 2026 | Presentations | — | 03026 | |
| 11 May 2026, 09:25 | Alterity Announces Publication on MRI as Biomarker for MSA | Company Update | — | 11001 | |
| 7 May 2026, 11:35 | Alterity to Deliver Presentations at May Medical Meetings | Company Administration | — | 12008 | |
| 30 Apr 2026, 11:45 | Consolidation/Split - ATH | Securities Administration | — | 06005, 06007 | |
| 30 Apr 2026, 09:53 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19003, 19008 | |
| 29 Apr 2026, 12:54 | Notice of General Meeting/Proxy Form | Presentations | MS | 06005, 08004, 08007, 14014, 16002 |
1–50 of 110
1 / 3